Provenienza dei contatti di primo grado di Ofir Moreno
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 | |
| Extinct | Medical Specialties | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ofir Moreno tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal Founder | |
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
| MYMETICS CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Treasurer Director of Finance/CFO | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Sales & Marketing | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
| KURA ONCOLOGY, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Virginia Mason Medical Center
 Virginia Mason Medical Center Medical/Nursing ServicesHealth Services Virginia Mason Medical Center provides healthcare services. It offers primary and cancer care, diabetes center, digestive disorders, heart care, neurology and neurosurgery, medicine, surgery, urology, and orthopedics and sports. The company was founded by James Tate Mason, John M. Blackford, and Maurice Dwyer in 1920 and is headquartered in Seattle, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| McGill University | College/University | Undergraduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin Graduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| George Mason University | College/University | Undergraduate Degree Undergraduate Degree | |
| Seattle University | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University | College/University | Masters Business Admin Graduate Degree | |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| PHASERX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Virginia Mason Health System
 Virginia Mason Health System Hospital/Nursing ManagementHealth Services Virginia Mason Health System offers medical services. It is the parent company of a group of affiliated organizations including Virginia Mason Medical Center and the Benaroya Research Institute at Virginia Mason. The firm support the healthcare and research missions of the Virginia Mason Medical Center and Benaroya Research Institute at Virginia Mason. The company was founded in 1920 and is headquartered in Seattle, WA. | Hospital/Nursing Management | Director/Board Member Director/Board Member | |
The Hope Funds for Cancer Research
 The Hope Funds for Cancer Research Miscellaneous Commercial ServicesCommercial Services The Hope Funds for Cancer Research provides funds for cancer research. The private company is based in Newport, RI. The company was founded by Leah Rush Cann. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| NEVIS BRANDS INC. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director of Finance/CFO | |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
BioEclipse Therapeutics, Inc.
 BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IMMUNITYBIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Canada | 3 |
| Regno Unito | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 35 |
| Consumer Services | 13 |
| Health Services | 3 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 167 |
| Corporate Officer/Principal | 95 |
| Independent Dir/Board Member | 66 |
| Director of Finance/CFO | 52 |
| Undergraduate Degree | 42 |
Contatti più connessi
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Bryan Williams | 22 |
| Gregory Schiffman | 22 |
| Fred Driscoll | 21 |
| Cheryl Cohen | 20 |
| Peter García | 19 |
| Christopher Henney | 18 |
| Michelle Griffin | 18 |
| Julia Eastland | 16 |
| Robert Hershberg | 16 |
| Charles Baltic | 15 |
| Richard B. Brewer | 14 |
| Martin Simonetti | 13 |
| Richard Ghalie | 13 |
| Richard F. Hamm | 11 |
- Borsa valori
- Insiders
- Ofir Moreno
- Connessioni Società
